Therefore, our findings from this study on the enhanced sensitivity of pancreatic cancer cells to chemotherapy drugs by siRNA-mediated APE2-KD or Celastrol-mediated APE2 inhibition is in with the overall concept that suppressing regulators of the ATR DDR pathway can enhance efficacy of chemotherapies. This evidence concerns the gene ATR and familial pancreatic carcinoma.